PREVIEW ASH 2026 — New Orleans, Dec 12–15: the abstracts hematologists are watching, top voices and trial buzz See the ASH 2026 preview →
KOL PULSE AI
#ESMO26 · POST-CONFERENCE EDITION · Influencer Networks

ESMO 2026 Lung:
Who Drove the Conversation?

Post-conference edition, data through October 30, 2026 · ESMO Congress 2026 · October 23–27, 2026 · Madrid, Spain · 947 curated #ESMO26 posts on 24 lung cancer trials · interactive retweet/mention graph. Companion to the KOL Pulse ESMO 2026 conference coverage and lung slide library.

1,209
Accounts Analyzed
1,209
Classified Accounts
197
Verified US Physicians
53
Physician Countries
See the ESMO 2026 conference coverage → ESMO 2026 lung slide library → ESMO 2026 Lung attendee network →
›
How to Use This Report
A working tool for post-meeting follow-up, not a leaderboard for its own sake

After the meeting: click any KOL card to isolate their retweet graph and see who moved their content; click a state on the map or a country card to pull the verified physicians there with institution and trial interests — the physicians who engaged with the ESMO 2026 lung data, organized the way you plan territory. For trial-by-trial physician rosters, use the trial section of the ESMO 2026 Lung attendee network.

Reading the network: node size is reach, edges are actual retweets and mentions from the conference window — not follower counts. Clusters show which communities (US academic, community practice, patient organizations, media) organized around which sessions and topics.

Amplifiers vs authors: the leaderboard ranks who writes; the amplifier board below ranks who spreads. If you want a message carried to the #ESMO26 lung cancer audience, the amplifier list is the distribution map.

Data through October 30, 2026. Post-conference edition covering physician and community discussion of 24 lung cancer trials at ESMO Congress 2026 (Madrid, Spain, October 23–27, 2026; #ESMO26). Trials covered: KRASCENDO-1, SAFFRON, OptiTROP-Lung06, PERSEE, DeLLphi-305, DeLLphi-304, OptiTROP-Lung04, PANKU-Lung01, SARON, HERON-Lung01, SANOVO, Neotorch, SigVie-002, dalmelitinib (HS-10241-301), NeoCOAST-2, ASTRIDE, SUNRAY-01, DIAL, PACE-Lung, ROSETTA-Lung107, PEARLS (KEYNOTE-091), KEYNOTE-671, OSE2101 (Combi-TED), COCOON.

1
Top KOLs by Impression
Click any KOL to filter the network below to just their retweeter graph. Trial presenters are included even if they did not post.
#1
Hidehito HORINOUCHI
@hhorinouchi
81.6K imp · 56 tweets
Kol
#2
Stephen V Liu, MD
@stephenvliu
63.8K imp · 29 tweets
Us Kol
#3
Yakup Ergün
@dr_yakupergun
43.8K imp · 15 tweets
Kol
#4
Masahiro TORASAWA, MD. P
@m_torasawa
40.0K imp · 6 tweets
Kol
#5
Oncology Brothers
@oncbrothers
31.0K imp · 8 tweets
Us Kol
#6
Enes Erul MD
@erulenes
24.4K imp · 2 tweets
Kol
#7
Dr Amol Akhade
@suyogcancer
20.4K imp · 10 tweets
Kol
#8
Giannis Mountzios
@g_mountzios
20.0K imp · 7 tweets
Kol
#9
Patrick Forde
@fordepatrick
19.9K imp · 9 tweets
Kol
#10
Rami Manochakian MD, FAS
@rmanochakian
19.1K imp · 7 tweets
Us Kol
Presenter
Jacob sands
@sands_jacob
Trial presenter
DeLLphi-305
Presenter
chantal decroisette
@decroisette
113 imp · 1 tweets
PERSEE
Presenter
Charlie Rudin
@charlesrudin
Trial presenter
DeLLphi-304
Presenter
Marina Garassino
@marinagarassino
Trial presenter
KEYNOTE-671
Presenter
Solange Peters
@peters_solange
Trial presenter
SigVie-002
Presenter
David Gandara
@drgandara
Trial presenter
ASTRIDE
Presenter
Fiona McDonald
@fifimcdrmh
Trial presenter
SARON
Presenter
Ferdinandos Skoulidis
@fskoulidis
Trial presenter
KRASCENDO-1
Presenter
Byoung Chul Cho, M.D., P
@cbcbc1971
Trial presenter
ROSETTA-Lung107
Presenter
Federico Cappuzzo
@federicocappuz1
Trial presenter
OSE2101 (Combi-TED)
★
Top Amplifiers — Recognition Board
The accounts that spread the #ESMO26 lung cancer conversation: most corpus posts retweeted or quoted
#1
Chidambara .ML.
@chidambara09
210 posts reposted/quoted
Industry
#2
Stefania Colasanti
@stefani19753108
200 posts reposted/quoted
Community
#3
OncoAlert
@oncoalert
145 posts reposted/quoted
Media
#4
Hidehito HORINOUCHI
@hhorinouchi
114 posts reposted/quoted
Int'l Physician
#5
Nirmal Raut
@oncologician
105 posts reposted/quoted
Int'l Physician
#6
Gil Morgan, MD
@weoncologists
81 posts reposted/quoted
Media
#7
gilberto lopes
@glopesmd
58 posts reposted/quoted
US Physician
#8
AcuVox
@oncoreporte
53 posts reposted/quoted
Media
#9
Rami Manochakian MD, FASCO
@rmanochakian
40 posts reposted/quoted
US Physician
#10
Stephen V Liu, MD
@stephenvliu
40 posts reposted/quoted
US Physician
#11
Santhosh Ambika
@renohemonc
35 posts reposted/quoted
US Physician
#12
AMRANE Karim
@amranekarim6
29 posts reposted/quoted
Int'l Physician
2
Category Breakdown
Voice composition across the 1,209 accounts identified
Intl Physicians
353
US Physicians
197
General Public
195
Bot/Inactive
108
Media (medical + finance)
96
Researchers
71
Patient Organizations
42
Pharma Industry
29
Institutions
28
Physician_Unclassified_Country
21
Tech/Health
19
Conference Organizations
16
Pharma Companies
12
Pharma Individual
11
Pharmacists
5
Nurse/APP
2
Investors
2
Practice_Admin
1
Larvol_Fans
1
3
Verified US Physicians by State
167 of 197 verified US physicians mapped across 36 states
Verified US physicians 1 2–3 4–5 6+ Click any state to see physicians
4
Non-US Physicians by Country
353 verified non-US physicians in 52 countries outside the US · 53 physician countries including the US (an additional 0 physician-like accounts have no country evidence)
Free Access · KOL Pulse Intelligence

Track oncology’s top KOLs in your specialty

Create a free account, pick the tumor types you cover, and go beyond the tweet — the intelligence pharma teams use to map influence and prepare for engagement:

  • ✓Enhanced KOL profiles
  • ✓Pharma influence & potential advisory-board patterns
  • ✓2025 Open Payments financial analysis
  • ✓Social-media sentiment & trend signals
Get free access — pick your specialty
Choose the tumor types you follow. No cost, unsubscribe anytime.
5
Influencer Network
Force-directed retweet graph — 680 nodes, 1923 edges. Drag, zoom, click nodes for details.
View:
US Influence:
Other:
Top 10 KOL networks:
US Physicians KOLs Media Institutions Pharma Retweeters
6
Top KOL Voices
Highest-impact physician/researcher voices — institutional and media accounts excluded
AccountCategoryInstitutionLocationTop Trials (their posts)TweetsImpressions
Hidehito HORINOUCHI
Intl KOLNational Cancer Center Hospital, TokyoJapan
KRASCENDO-1 · 8SAFFRON · 8DeLLphi-305 · 8
5681.6K
Stephen V Liu, MD
US KOLMedStar Georgetown University Hospital /DC
PERSEE · 3KRASCENDO-1 · 2OptiTROP-Lung06 · 2
2963.8K
Yakup Ergün
Intl KOLÖzel Bower Hastanesi (Bower Hospital), DTurkey
KRASCENDO-1 · 4PERSEE · 3SAFFRON · 2
1543.8K
Masahiro TORASAWA, MD. PhD.
Intl KOLJuntendo UniversityJapan
PERSEE · 3KRASCENDO-1 · 2SAFFRON · 2
640.0K
Oncology Brothers
US KOLRoswell Park Comprehensive Cancer CenterNY
SAFFRON · 3DeLLphi-305 · 3KRASCENDO-1 · 2
831.0K
Enes Erul MD
Intl KOLAnkara UniversityTurkey
DeLLphi-305 · 2
224.4K
Dr Amol Akhade
Intl KOLFortis Hospital Mulund, MumbaiIndia
DeLLphi-305 · 4KRASCENDO-1 · 3SAFFRON · 3
1020.4K
Giannis Mountzios
Intl KOLHenry Dunant Hospital Center, AthensGreece
DeLLphi-305 · 4SAFFRON · 1OptiTROP-Lung06 · 1
720.0K
Patrick Forde
Intl KOLTrinity St James's Cancer Institute (TriIreland
NeoCOAST-2 · 5PERSEE · 1DeLLphi-305 · 1
919.9K
Rami Manochakian MD, FASCO
US KOLMayo ClinicFL
DeLLphi-305 · 3SAFFRON · 2KRASCENDO-1 · 1
719.1K
Alfredo Addeo MD
Intl KOLUniversity Hospital of GenevaSwitzerland
PERSEE · 5DeLLphi-305 · 3SARON · 3
1918.7K
MV Chandrakanth
Intl KOLNH Rabindranath Tagore Institute / NarayIndia
SAFFRON · 3DeLLphi-305 · 3ASTRIDE · 3
1618.6K
Toni Choueiri, MD
US KOLDana-Farber Cancer InstituteMA
DeLLphi-305 · 4KRASCENDO-1 · 3SAFFRON · 3
815.0K
Dr Rishabh Jain
Intl KOLAll India Institute of Medical Sciences India
KRASCENDO-1 · 3SAFFRON · 3PERSEE · 3
1114.4K
Aakash Desai
US KOLUAB — O'Neal Comprehensive Cancer CenterAL
SAFFRON · 2OptiTROP-Lung06 · 2DeLLphi-305 · 2
1413.7K
ilyas sahin, MD
US KOLMassachusetts General HospitalMA
KRASCENDO-1 · 1PERSEE · 1DeLLphi-305 · 1
313.0K
Jeff Ryckman
US KOLWVU Medicine Camden Clark Medical CenterWV
DeLLphi-305 · 3OptiTROP-Lung06 · 2PERSEE · 2
1211.6K
Dr. Antonio Calles
Intl KOLHospital General Universitario Gregorio Spain
SAFFRON · 2DeLLphi-305 · 2KRASCENDO-1 · 1
1110.6K
Jose Fernando Moura, PhD
Intl KOLReal Hospital Português, RecifeBrazil
DeLLphi-305 · 5PANKU-Lung01 · 2HERON-Lung01 · 2
189.8K
Clive Peedell
Intl KOLJames Cook University Hospital (South TeUK
KRASCENDO-1 · 1SAFFRON · 1OptiTROP-Lung06 · 1
59.5K
Dr. Estela Rodriguez
US KOLUniversity of Miami Sylvester ComprehensFL
SAFFRON · 5DeLLphi-305 · 4KRASCENDO-1 · 3
179.5K
Noemi Reguart
Intl KOLHospital Clínic de BarcelonaSpain
DeLLphi-305 · 3SAFFRON · 1PERSEE · 1
69.1K
Balazs Halmos
US KOLMontefiore EinsteinNY
DeLLphi-305 · 2KRASCENDO-1 · 1OptiTROP-Lung06 · 1
69.1K
Tom Newsom-Davis
Intl KOLChelsea and Westminster HospitalUK
KRASCENDO-1 · 1SAFFRON · 1PERSEE · 1
68.9K
Prof Tom John
Intl KOLPeter MacCallum Cancer Centre, MelbourneAustralia
SAFFRON · 4KRASCENDO-1 · 2OptiTROP-Lung06 · 2
188.8K
Ben Solomon
Intl KOLPeter MacCallum Cancer CentreAustralia
KRASCENDO-1 · 2
27.9K
Dr Riyaz Shah
Intl KOLKent Oncology Centre, Maidstone & TunbriUK
DeLLphi-305 · 3DeLLphi-304 · 2KRASCENDO-1 · 1
187.8K
Anirban Maitra
US KOLNYU Langone Perlmutter Cancer Center (DiNY
DeLLphi-305 · 2KRASCENDO-1 · 1
37.2K
Aya Mohamed
US KOL-NY
OptiTROP-Lung06 · 2DeLLphi-304 · 2ASTRIDE · 2
127.0K
Julien Mazieres
Intl KOLToulouse University Hospital (CHU de TouFrance
KRASCENDO-1 · 1PERSEE · 1DeLLphi-305 · 1
46.6K
Are you on this map?

Are you a KOL?

Want to learn more about your network — your reach, engagement, and influence across ESMO 2026 and the wider lung cancer conversation? Sign up for a free custom KOL report.

?
Questions This Network Answers
The data on this page, summarized — and how to actually use it

What does this network show?

A force-directed map of who actually drove the #ESMO26 lung cancer conversation across 24 lung trials: a network graph of 680 of the 1,209 accounts analyzed, connected by 1923 real retweet, quote, and mention relationships from the conference and post-conference window (data through October 30, 2026) — not follower counts. 332 of the accounts shown in the network graph are verified physicians; across all 1,209 accounts analyzed, 197 US and 353 international physicians come from 53 physician countries. The leaderboard ranks the authors; the amplifier board ranks the 884 accounts doing the spreading — led by Chidambara .ML. who reposted or quoted 210 posts.

Who does a KOL influence — and who amplifies their content?

Take Hidehito HORINOUCHI, the top voice on the leaderboard: 114 distinct accounts reposted or quoted their posts, 316 times in all. The makeup of that amplifier network: 55 physicians, 7 patient advocates, 7 media accounts — a clinical audience, not bot inflation. The US physicians who amplify this content most: Prantesh Jain MD, FACP (8), Rami Manochakian MD, FASCO (7), Santhosh Ambika (4), Jacob sands (2); internationally, Nirmal Raut (13), Dr Akhil Santhosh MD DM MRCP(UK) (11). That is the practical answer to “who do they influence?”: the named, verified carriers who move a KOL’s content into each community. Click any KOL card above to run the same analysis visually on their retweeter graph.

How can medical affairs and pharma teams use this network?

Engagement sequencing: the leaderboard tells you who writes, the amplifier board tells you who spreads, and the edges tell you which specific accounts connect them. If a readout needs to reach the US and international lung oncology audience that followed the ESMO 2026 lung readouts, the amplifier list is the distribution map — and influence-mapping practice guides note that knowing the carriers prevents redundant outreach to already-saturated voices. Pair with the ESMO 2026 Lung attendee network for rosters by region, institution, and trial interest.

Why does influence mapping matter in oncology?

Congress weeks are when oncology opinion forms: standards shift with each readout and physicians learn about the data from each other in real time — surveys report over 70% of HCPs use digital channels weekly, and in a LiveWorld–Sermo survey, 41% of US physicians said social media influences prescribing. Publication records show who built the evidence; this graph shows who carries it — measured in actual retweet relationships from the meeting itself.

How can I use this network with my favorite AI tool?

Paste this URL into ChatGPT, Gemini, Claude, or Perplexity and ask the questions this graph answers: “Who are the top amplifiers of #ESMO26 lung cancer content and what kinds of accounts are they?”, “What is the makeup of Hidehito HORINOUCHI’s amplifier network?”, “Which US physicians amplify the leading international voices?” For who-engaged questions (regions, institutions, trial interests), use the ESMO 2026 Lung attendee network. Cite kolpulse.com when you share the answers.